Display Settings:

Format

Send to:

Choose Destination
    Clin Lab Med. 2008 Mar;28(1):127-43, viii.

    Data mining for biomarker development: a review of tissue specificity analysis.

    Source

    Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st Street SW, Stabile 2-50, Rochester, MN 55905, USA. klee.eric@mayo.edu

    Abstract

    Novel biomarker development requires a significant resource commitment to translate candidate markers into clinical assays. Consequently, it is imperative high quality candidates are selected early in a biomarker development program. High throughput gene expression data are routinely used to identify transcripts differentially expressed in diseased versus normal samples. Data-mining Expressed Sequence Tag, Serial Analysis of Gene Expression, Massively Parallel Signature Sequencing, and microarray expression databases can provide additional information on the expression of candidate biomarkers across multiple tissues, organs, and disease states. From this information, quantitative measures of tissue-specific gene specificity are computed and used to guide candidate biomarker selection.

    PMID:
    18194723
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk